{
  "id": "620086aac9dfcb9c09000020",
  "type": "summary",
  "question": "What is the use of Brain Metastasis Velocity (BMV) Model?",
  "ideal_answer": "Brain metastasis velocity (BMV) is a metric that describes the rate of development of new brain metastases (BM) after initial stereotactic radiosurgery.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31526671",
    "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
    "http://www.ncbi.nlm.nih.gov/pubmed/34775780",
    "http://www.ncbi.nlm.nih.gov/pubmed/29740743",
    "http://www.ncbi.nlm.nih.gov/pubmed/30524969",
    "http://www.ncbi.nlm.nih.gov/pubmed/29464141",
    "http://www.ncbi.nlm.nih.gov/pubmed/28586952"
  ],
  "snippets": [
    {
      "text": "PURPOSE/OBJECTIVE(S): Brain metastasis velocity (BMV) is a metric that describes the rate of development of new brain metastases (BM) after initial stereotactic radiosurgery (SRS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29740743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Brain metastasis velocity (BMV) predicts outcomes after initial distant brain failure (DBF) following upfront stereotactic radiosurgery (SRS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "lso tells the history of the derivation and validation of BMV, a recently identified biomarker for survival and neurologic death in the brain metastasis population treated with SRS.CONC",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34775780",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To provide a review of the current status of predictive nomograms and brain metastasis velocity (BMV) in the prognostication of brain metastasis outcomes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34775780",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Brain metastasis velocity (BMV) is a prognostic metric that describes the recurrence rate of new brain metastases after initial treatment with radiosurgery (SRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31526671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Brain metastasis velocity (BMV) predicts outcomes after initial distant brain failure (DBF) following upfront stereotactic radiosurgery (SRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We introduce a novel clinical metric, brain metastasis velocity (BMV), for predicting clinical outcomes after initial DBF following upfront SRS alone.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586952",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE/OBJECTIVE(S): Brain metastasis velocity (BMV) is a metric that describes the rate of development of new brain metastases (BM) after initial stereotactic radiosurgery (SRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29740743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "e. We introduce a novel clinical metric, brain metastasis velocity (BMV), for predicting clinical outcomes after initial DBF following upfront SRS alone",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586952",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Brain metastasis velocity (BMV) is a prognostic metric that describes the recurrence rate of new brain metastases after initial treatment with radios",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31526671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To provide a review of the current status of predictive nomograms and brain metastasis velocity (BMV) in the prognostication of brain metastasis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34775780",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE/OBJECTIVE(S): Brain metastasis velocity (BMV) is a metric that describes the rate of development of new brain metastases (BM) after initial stereotactic ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29740743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SRS). We developed an integrated model of clinical predictors and pre-SRS MRI-derived radiomic scores (R-scores) to identify high-BMV (BMV-H) patients upon initial identification of brain metastases (BM",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE/OBJECTIVE(S): Brain metastasis velocity (BMV) is a metric that describes the rate of development of new brain metastases (BM) after initial stereotact",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29740743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Brain metastasis velocity (BMV) is a prognostic metric that describes the recurrence rate of new brain metastases after initial treatment with radio",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31526671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Brain metastasis velocity (BMV) predicts outcomes after initial distant brain failure (DBF) following upfront stereotactic radiosu",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Besides clinical and treatment related factors, brain metastasis velocity (BMV) as a newly described clinical prognostic metric was included and calculated between first and second treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30524969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "stasis velocity (vBMV) was defined as the volume of new intracranial disease at the time of distant brain failure (DBF) for the first DBF (DBF1) and s",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29464141",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}